Emerging Therapeutic Discovery Against Escherichia coli Infection by Rational Inhibition of Fatty Acid Responsive Transcription Factor: Theoretical Molecular Investigations of Some Metabolites as Inhibitors of Fatty Acid Metabolism Protein

Tomy Muringayil Joseph, Debarshi Kar Mahapatra

Abstract


 

For the discovery of effective agent for overcoming resistance against Escherichia coli (E. coli) bacteria by modulating Fatty Acid Metabolism Protein (FadR)—a Fatty Acid Responsive Transcription Factor. The present study involved discovery of some metabolites of furan, furan-2-yl, macrolactin, and chromene scaffold via in silico structure-based drug design (SBDD) technique by utilizing the Maestro 9.1 software. The study will provide clues, motivate, and throw light on imperative aspects for the globally working medicinal chemists in the rational designing of anti-infective drugs in the near future.

 

Keywords: Chromene, FadR, furan, furan-2-yl, macrolactin

Cite this Article

Joseph TM, Mahapatra DK. Emerging Therapeutic Discovery against Escherichia coli Infection by Rational Inhibition of Fatty Acid Responsive Transcription Factor: Theoretical Molecular Investigations of some Metabolites as Inhibitors of Fatty Acid Metabolism Protein. Research & Reviews: Journal of Computational Biology. 2018; 7(3): 1–7p


Keywords


Chromene, FadR, Furan, Furan-2-yl, Macrolactin, Docking

Full Text:

PDF

References


Allocati N, Masulli M, Alexeyev MF, Di Ilio C. Escherichia coli in Europe: an overview. Int J Environ Res Public Health. 2013;10(12):6235-54p.

Mahapatra DK, Bharti SK. Handbook of Research on Medicinal Chemistry. 1st ed. Apple Academic Press, New Jersey, 2017.

Fujita Y, Matsuoka H, Hirooka K. Regulation of fatty acid metabolism in bacteria. Mol Microbiol. 2007;66(4):829-39p.

Van Aalten DM, DiRusso CC, Knudsen J, Wierenga RK. Crystal structure of FadR, a fatty acid‐responsive transcription factor with a novel acyl coenzyme A‐binding fold. EMBO J. 2000;19(19):5167-77p.

DiRusso CC, Heimert TL, Metzger AK. Characterization of FadR, a global transcriptional regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by long chain fatty acyl coenzyme A. J Biol Chem. 1992;267(12):8685-91p.

Mahapatra DK, Das D, Shivhare RS. Substituted thiazole linked murrayanine-Schiff’s base derivatives as potential anti-breast cancer candidates: Future EGFR Kinase inhibitors. Int J Pharm Sci Drug Res. 2017;9(3):139-44p.

Chhajed SS, Chaskar S, Kshirsagar SK, Haldar AGM, Mahapatra DK. Rational design and synthesis of some PPAR-γ agonists: substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones. Comp Biol Chem. 2017;67:260-5p.

Mahapatra DK, Das D, Shivhare RS, Borkar SS. Murrayanine-hydantoin and -thiohydantoin analogs as promising anti-convulsant agents: Synthesis, Characterization and Molecular Docking Studies. MOJ Bioorg Org Chem. 2018;2(2):47-51p.




DOI: https://doi.org/10.37591/rrjocb.v7i3.496

Refbacks

  • There are currently no refbacks.